Skip to main content

Table 6 Comparison of the incidence of adverse reactions in the treated group and the control group

From: Efficacy of rTMS for poststroke epilepsy and its effects on patients’ cognitive function and depressive status

 

n

No adverse reactions

Dizziness

Headache

Nausea

drowsiness

Incidence of adverse reactions (%)

χ2

P

Treated

53

45

2

3

1

1

13.46

0.001

0.971

Control

68

59

3

2

1

3

13.24